Purple Biotech Ltd. (PPBT) KPIs and segments
Close on Nov 12, 2026Market cap $1.45MP/E 0.0Yield –
KPIs & segments
Operating metrics and segments that drive Purple Biotech's business
Purple Biotech's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
Oncology($M) | -2.82 | -3.22 | -1.95 | ||
Pain and Hypertension($M) | -3.07 | -4.73 | -6.67 | ||
Earlier reporting (last reported 2020)2 | |||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2021-03-16.
See a number that looks wrong?